2022. Use of eculizumab in atypical hemolytic uremic syndrome associated with impaired renal function: integrative review. Archives Health Sciences. 26, 1 (Dec. 2022), 72–75. DOI:https://doi.org/10.17696/2318-3691.26.1.2019.1222.